Minnesota HF 3664: Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.

Status: Author added Hemmingsen-Jaeger (as of 2024-03-18)

State: Minnesota · Session: 2023-2024 · Bill: HF 3664

Subjects: Hospitals and Health Facilities, Human Services and Human Services Department

Sponsors: Bierman, Hemmingsen-Jaeger, Nadeau, Reyer

View Minnesota HF 3664 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.